As a leading specialist diagnostic company, our mission is to deliver improved outcomes for patients in our selected fields of speciality. We deliver innovative and effective assays, and instruments of the highest quality. We actively encourage the discovery of novel biomarkers in our selected specialist fields, and ultimately drive towards their successful commercialisation.
The strategic intent of IDS is to hold a leadership position in specialist diagnostics. Our aim is to compliment the products supplied by the main diagnostic providers rather than compete with them. We continue to develop and market both manual and fully automated specialist immunoassay testing solutions for both the Research and Clinical laboratory markets.
The increase in the aging population throughout the world has resulted in a higher incidence of conditions such as osteoporosis, rheumatoid and osteoarthritis, renal and cardiovascular disease. The spiralling socio-economic costs of fractures and other age-related morbidities are driving the need for better tools to monitor health and diagnose disease onset much earlier. The goal of IDS is to satisfy this need.
At IDS we continually strive to deliver the highest quality in all aspects of our operations. It is vital that the service we provide to our customers is of the highest standard. A robust and well-structured Technical Service function is essential to maintaining product quality and customer trust. IDS has successfully established a strong technical support function for our range of manual products and IDS-iSYS products .
The IDS Group has 3 manufacturing sites in Europe; in UK, France, and Belgium. Each site has ISO 13485 Medical Device Quality Management System certification All products manufactured by IDS are CE marked, and in addition many of our products, including the IDS-iSYS instrument, the IDS-iSYS Vitamin D assay, and several other IDS-iSYS assays have clearance granted by the US Food and Drugs Administration (FDA) for sale in the USA.